{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:35:24Z","timestamp":1790800524078,"version":"4.1.0"},"reference-count":20,"publisher":"FapUNIFESP (SciELO)","issue":"5","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x20155034","type":"journal-article","created":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:54:02Z","timestamp":1459990442000},"source":"Crossref","is-referenced-by-count":10,"title":["Genetic aberrations in multiple myeloma characterized by cIg-FISH: a Brazilian context"],"prefix":"10.1590","volume":"49","author":[{"given":"P.","family":"Segges","sequence":"first","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Braggio","sequence":"additional","affiliation":[{"name":"Mayo Clinic in Arizona,  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Minnicelli","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brasil; Universidade Federal do Rio Grande do Norte,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.R.","family":"Zalcberg","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Maiolino","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2016]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle RA","year":"2008","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3324\/haematol.11637","article-title":"Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma","volume":"93","author":"Hungria VT","year":"2008","journal-title":"Haematologica"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2003-02-0493","article-title":"The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma","volume":"102","author":"Fonseca R","year":"2003","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/asheducation-2005.1.346","article-title":"Early genetic events provide the basis for a clinical classification of multiple myeloma","author":"Kuehl WM","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","article-title":"Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome","volume":"26","author":"Decaux O","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/leu.2012.128","article-title":"SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status","volume":"26","author":"Lopez-Corral L","year":"2012","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2010-10-300970","article-title":"Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2","volume":"117","author":"Munshi NC","year":"2011","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/ajh.23274","article-title":"Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma","volume":"87","author":"Maiolino A","year":"2012","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","article-title":"Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders","volume":"97","author":"Ross FM","year":"2012","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia","volume":"22","author":"Tiedemann RE","year":"2008","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2004.04867.x","article-title":"The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant","volume":"125","author":"Chang H","year":"2004","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","article-title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","volume":"101","author":"Keats JJ","year":"2003","journal-title":"Blood"},{"issue":"(Suppl 1)","key":"ref13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/11.suppl_1.S131","article-title":"Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma","volume":"11","author":"Chesi M","year":"2000","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"Zhan F","year":"2006","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1590\/S0100-879X2012007500135","article-title":"Evaluation of chromosomal abnormalities by cIg-FISH and association with proliferative and apoptotic indexes in multiple myeloma","volume":"45","author":"Linardi CC","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca R","year":"2003","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1200\/JCO.2010.28.3945","article-title":"Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p)","volume":"28","author":"Avet-Loiseau H","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.leu.2404459","article-title":"Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion","volume":"21","author":"Sagaster V","year":"2007","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5581\/1516-8484.20140008","article-title":"Outcomes of autologous transplantation for multiple myeloma according to different induction regimens","volume":"36","author":"Crusoe Ede Q","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000000746","article-title":"Cancer mortality in Brazil: temporal trends and predictions for the year 2030","volume":"94","author":"Barbosa IR","year":"2015","journal-title":"Medicine"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v49n5\/1414-431X-bjmbr-1414-431X20155034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T16:00:50Z","timestamp":1581091250000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2016000500701&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016]]}},"alternative-id":["S0100-879X2016000500701"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x20155034","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"article-number":"e5034"}}